P. Luoma

发表

ANTIOXIDANTS, DIET AND MORTALITY FROM ISCHAEMIC HEART DISEASE IN RURAL COMMUNITIES IN NORTHERN FINLAND

J. Hassi, S. Näyhä, P. Luoma, 1996 .

Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity.

P. Luoma, 1997, Pharmacology & toxicology.

High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects

J. Marniemi, A. Rautio, E. Sotaniemi, 2004, European Journal of Clinical Pharmacology.

High serum alpha‐tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland *

J. Hassi, S. Näyhä, P. Luoma, 1995, Journal of internal medicine.

Plasma high-density lipoproteins and hepatic microsomal enzyme induction

C. Ehnholm, E. Sotaniemi, A. Arranto, 1982, European Journal of Clinical Pharmacology.

Plasma HDL cholesterol and blood glucose in non-insulin-dependent diabetics related to liver lipids and microsomal enzyme activity.

M. Savolainen, E. Sotaniemi, A. Arranto, 2009, Acta medica Scandinavica.

Treatment of alcoholic cirrhosis with enzyme inducers

A. Rautio, E. Sotaniemi, P. Luoma, 1980, Clinical pharmacology and therapeutics.

Serum selenium, glutathione peroxidase, lipids, and human liver microsomal enzyme activity

J. Kumpulainen, E. Sotaniemi, H. Korpela, 1985, Biological Trace Element Research.

Plasma HDL cholesterol and growth hormone in epileptics treated with anticonvulsants.

V. Myllylä, E. Sotaniemi, T. Hokkanen, 2009, Acta pharmacologica et toxicologica.

Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment.

V. Myllylä, E. Sotaniemi, R. Pelkonen, 1980, Scandinavian journal of clinical and laboratory investigation.

Plasma HDL cholesterol in epileptics with elevated triglyceride and cholesterol

V. Myllylä, E. Sotaniemi, T. Hokkanen, 1979, Acta neurologica Scandinavica.

Drug metabolism in diabetic subjects with fatty livers.

U. Pitkänen, P. Salmela, E. Sotaniemi, 1984, British journal of clinical pharmacology.

Pharmac . ( 1975 ) , 2 , 429-436 HEPATIC DRUG-OXIDIZING ENZYME SYSTEMS AND URINARY D-GLUCARIC ACID EXCRETION IN PATIENTS WITH CONGESTIVE HEART FAILURE

N. Karki, P. Luoma, 2006 .

Histological changes in the liver and indices of drug metabolism in alcoholics

E. Sotaniemi, R. Pelkonen, P. Luoma, 1977, European Journal of Clinical Pharmacology.

Microsomal enzyme induction, lipoproteins and atherosclerosis.

P. Luoma, 1988, Pharmacology & toxicology.

Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure.

O. Pelkonen, N. Karki, P. Luoma, 1975, British journal of clinical pharmacology.

Serum Lipid Levels and M/L55 Allele Distribution of HDL Paraoxonase Gene in Saami and Finnish Men

T. Lehtimäki, T. Koivula, S. Lehtinen, 2001, International journal of circumpolar health.

Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol--effect of selenium supplementation.

J. Kumpulainen, E. Sotaniemi, H. Korpela, 1984, Research communications in chemical pathology and pharmacology.

Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants.

V. Myllylä, E. Sotaniemi, P. Luoma, 1980, European neurology.

Changes in serum triglyceride and cholesterol levels during long-term phenytoin treatment for epilepsy.

M. Reunanen, E. Sotaniemi, P. Luoma, 2009, Acta medica Scandinavica.

Apolipoprotein A-IV polymorphism in Saami and Finns: frequency and effect on serum lipid levels.

T. Lehtimäki, T. Nikkari, T. Koivula, 1998, Annals of medicine.

HEPATICDRUG-OXIDIZING ENZYMESYSTEMS AND URINARYD-GLUCARIC ACIDEXCRETION INPATIENTSWITHCONGESTIVEHEARTFAILURE

T. Larmi, P. Luoma, N. Kärki, 1975 .

Low high-density lipoprotein and reduced antipyrine metabolism in members of a family with polycystic liver disease.

C. Ehnholm, E. Sotaniemi, P. Luoma, 1980, Scandinavian journal of gastroenterology.

Relationship between lipid composition and drug metabolizing capacity of human liver

M. Savolainen, I. Hassinen, E. Sotaniemi, 2004, European Journal of Clinical Pharmacology.

High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers.

C. Ehnholm, E. Sotaniemi, R. Pelkonen, 1982, Research communications in chemical pathology and pharmacology.

INDUCTION AND LIPOPROTEINS

M. Savolainen, C. Ehnholm, E. Sotaniemi, 1982, The Lancet.

Decreased serum selenium in alcoholics as related to liver structure and function.

J. Kumpulainen, E. Sotaniemi, A. Arranto, 1985, The American journal of clinical nutrition.

Cytochrome P450 — physiological key factor against cholesterol accumulation and the atherosclerotic vascular process

P. Luoma, 2007, Annals of medicine.

Changes in Thyroid Function Tests During Phenobarbital Treatment in Late Pregnancy

P. Ylöstalo, P. Luoma, J. E. Heikkinen, 1980, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Studies on drugs affecting the choledochoduodenal junction in rabbits.

P. Luoma, 2009, Acta pharmacologica et toxicologica.

Efficacy of Intravenous Disopyramide in the Termination of Supraventricular Arrhythmias

J. Takkunen, P. Luoma, H. Juustila, 1978, Journal of clinical pharmacology.

Antipyretic Effect and Plasma Concentrations of Rectal Acetaminophen and Diazepam in Children

S. Keinänen-Kiukaanniemi, L. Kangas, P. Luoma, 1979, Epilepsia.

The effect of phenobarbital on serum hormone levels and their diurnal variations in pregnancy.

P. Ylöstalo, J. Heikkinen, P. Luoma, 1984, Pharmacology.

Saliva and plasma clearance of antipyrine as reflectors of liver function

E. Sotaniemi, P. Luoma, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Gene-Activation Mechanisms in the Regression of Atherosclerosis, Elimination of Diabetes Type 2, and Prevention of Dementia

P. Luoma, 2011, Current molecular medicine.

Gene activation regresses atherosclerosis, promotes health, and enhances longevity

P. Luoma, 2010, Lipids in Health and Disease.

Gene-activators prevent and regress atherosclerosis and reduce mortality.

P. Luoma, 2009, Cardiovascular & hematological agents in medicinal chemistry.

Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis

P. Luoma, 2008, European Journal of Clinical Pharmacology.

Antioxidants, infections and environmental factors in health and disease in northern Finland.

P. Luoma, 1998, International journal of circumpolar health.

Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases

P. Luoma, 2012, Annals of medicine.

The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.

J. Marniemi, E. Sotaniemi, P. Luoma, 1988, Research communications in chemical pathology and pharmacology.

One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function

P. Ylöstalo, J. Heikkinen, C. Ehnholm, 2004, European Journal of Clinical Pharmacology.

Liver histological changes and plasma high density lipoproteins in man.

C. Ehnholm, E. Sotaniemi, A. Arranto, 1981, Research communications in chemical pathology and pharmacology.

Lipid peroxides, glutathione peroxidase, high density lipoprotein subfractions and apolipoproteins in young adults

J. Stengård, J. Marniemi, A. Rautio, 1990, Journal of internal medicine.

Cytochrome P450 and gene activation – cholesterol elimination and regression of atherosclerosis: author reply to the commentary

P. Luoma, 2008, European Journal of Clinical Pharmacology.

Lysosomal enzymes in hepatic injury induced by bromobenzene.

P. Guzelian, P. Luoma, 1978, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

Differences in genetic variation of apolipoprotein E in Lapps and Finns

T. Nikkari, S. Lehtinen, J. Hassi, 1994 .

Impairment of drug metabolism in polycystic non-parasitic liver disease.

E. Sotaniemi, K. Sotaniemi, P. Luoma, 1979, British journal of clinical pharmacology.

Association of blood cadmium to the area of residence and hypertensive disease in Arctic Finland.

J. Hassi, S. Näyhä, L. Pyy, 1995, The Science of the total environment.

Enzyme-Inducers and High-Density Lipoproteins

P. Luoma, 1987 .

Changes in the hepatic microsomal enzyme activity during long-term ethanol feeding in rat.

P. Luoma, M. Vorne, 2009, Acta pharmacologica et toxicologica.

The combined effect of ethanol and phenobarbital on the activities of hepatic drug metabolizing enzymes in rats.

P. Luoma, M. Vorne, 2009, Acta pharmacologica et toxicologica.

Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme induction.

M. Savolainen, C. Ehnholm, E. Sotaniemi, 2009, Acta medica Scandinavica.

Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes

R. Pelkonen, P. Luoma, H. Pirttiaho, 2004, European Journal of Clinical Pharmacology.

Blood mercury and serum selenium concentrations in reindeer herders in the arctic area of northern Finland.

J. Hassi, L. Pyy, H. Korpela, 1992, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.